Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02044120 |
| Title | ESP1/SARC025 Global Collaboration: A Phase I Study of a Combination of the PARP Inhibitor, Niraparib and Temozolomide in Patients With Previously Treated, Incurable Ewing Sarcoma |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Sarcoma Alliance for Research through Collaboration |
| Indications | |
| Therapies | |
| Age Groups: | adult | child |
| Covered Countries | USA | GBR |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Children's Hospital of Los Angeles | Los Angeles | California | 90027 | United States | Details | |
| National Cancer Institute | Bethesda | Maryland | 20892 | United States | Details | |
| University of Michigan | Ann Arbor | Michigan | 48106 | United States | Details | |
| Seattle's Children Cancer Center | Seattle | Washington | 98101 | United States | Details | |
| University College London Hospital | London | W1T 7HA | United Kingdom | Details |